China to shift drug reimbursement from provincial authorities
Moving to centralize decision-making on drug reimbursement practices, China’s National Healthcare Security Administration has drafted a plan to decrease the ability of provincial governments to make adjustments to the prices of pharmaceuticals. The agency, which since its formation last November has played... Read More